BIGT.L vs. GNOG.L
Compare and contrast key facts about L&G Pharma Breakthrough UCITS ETF (BIGT.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L).
BIGT.L and GNOG.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BIGT.L is a passively managed fund by Legal & General that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Jan 18, 2018. GNOG.L is a passively managed fund by Global X that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Nov 2, 2021. Both BIGT.L and GNOG.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BIGT.L vs. GNOG.L - Performance Comparison
Loading graphics...
BIGT.L vs. GNOG.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BIGT.L L&G Pharma Breakthrough UCITS ETF | 2.41% | 27.03% | -3.16% | -14.88% | 2.68% | -5.66% |
GNOG.L Global X Genomics & Biotechnology UCITS ETF | -1.16% | 12.03% | -16.98% | -11.35% | -29.74% | -10.30% |
Different Trading Currencies
BIGT.L is traded in GBp, while GNOG.L is traded in GBP. To make them comparable, the GNOG.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, BIGT.L achieves a 2.41% return, which is significantly higher than GNOG.L's -1.16% return.
BIGT.L
- 1D
- 0.10%
- 1M
- 4.52%
- YTD
- 2.41%
- 6M
- 8.01%
- 1Y
- 29.68%
- 3Y*
- 4.63%
- 5Y*
- 2.85%
- 10Y*
- —
GNOG.L
- 1D
- 3.29%
- 1M
- -4.36%
- YTD
- -1.16%
- 6M
- 14.72%
- 1Y
- 37.00%
- 3Y*
- -4.91%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIGT.L vs. GNOG.L - Expense Ratio Comparison
BIGT.L has a 0.49% expense ratio, which is lower than GNOG.L's 0.50% expense ratio.
Return for Risk
BIGT.L vs. GNOG.L — Risk / Return Rank
BIGT.L
GNOG.L
BIGT.L vs. GNOG.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (BIGT.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIGT.L | GNOG.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.50 | 1.23 | +0.27 |
Sortino ratioReturn per unit of downside risk | 2.04 | 1.79 | +0.25 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.22 | +0.04 |
Calmar ratioReturn relative to maximum drawdown | 3.28 | 2.22 | +1.06 |
Martin ratioReturn relative to average drawdown | 9.86 | 6.61 | +3.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BIGT.L | GNOG.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.50 | 1.23 | +0.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.17 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.24 | -0.45 | +0.69 |
Correlation
The correlation between BIGT.L and GNOG.L is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
BIGT.L vs. GNOG.L - Dividend Comparison
Neither BIGT.L nor GNOG.L has paid dividends to shareholders.
Drawdowns
BIGT.L vs. GNOG.L - Drawdown Comparison
The maximum BIGT.L drawdown since its inception was -30.23%, smaller than the maximum GNOG.L drawdown of -67.50%. Use the drawdown chart below to compare losses from any high point for BIGT.L and GNOG.L.
Loading graphics...
Drawdown Indicators
| BIGT.L | GNOG.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.23% | -67.50% | +37.27% |
Max Drawdown (1Y)Largest decline over 1 year | -9.93% | -17.16% | +7.23% |
Max Drawdown (5Y)Largest decline over 5 years | -30.23% | — | — |
Current DrawdownCurrent decline from peak | -1.78% | -48.74% | +46.96% |
Average DrawdownAverage peak-to-trough decline | -10.71% | -44.07% | +33.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.30% | 5.75% | -2.45% |
Volatility
BIGT.L vs. GNOG.L - Volatility Comparison
The current volatility for L&G Pharma Breakthrough UCITS ETF (BIGT.L) is 7.52%, while Global X Genomics & Biotechnology UCITS ETF (GNOG.L) has a volatility of 9.63%. This indicates that BIGT.L experiences smaller price fluctuations and is considered to be less risky than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BIGT.L | GNOG.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.52% | 9.63% | -2.11% |
Volatility (6M)Calculated over the trailing 6-month period | 14.10% | 21.09% | -6.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.79% | 29.88% | -10.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.68% | 31.32% | -14.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.35% | 31.32% | -12.97% |